MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,727 Cr | ₹1,473 Cr | ₹1,334 Cr | ₹845 Cr | ₹604 Cr |
What is the latest Net Current Assets ratio of MARKSANS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,727 Cr |
| Mar2024 | ₹1,473 Cr |
| Mar2023 | ₹1,334 Cr |
| Mar2022 | ₹845 Cr |
| Mar2021 | ₹604 Cr |
How is Net Current Assets of MARKSANS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,727 Cr | 17.26 | |
| Mar2024 | ₹1,473 Cr | 10.37 | |
| Mar2023 | ₹1,334 Cr | 57.91 | |
| Mar2022 | ₹845 Cr | 39.93 | |
| Mar2021 | ₹604 Cr | - | |
Compare Net Current Assets of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹10,697.8 Cr | -2.3% | 18.7% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -2.3% |
18.7% |
-8.5% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses